Cargando…
COVID-19 and Peripheral Artery Thrombosis: A Mini Review
For more than 2 years, health care systems have been floundering in a massive crisis of coronavirus disease 2019 (COVID-19) pandemic. While acute respiratory distress syndrome is the main complication in patients with COVID-19, as the pandemic continues, more data about the nonrespiratory effects of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby-Year Book
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462005/ https://www.ncbi.nlm.nih.gov/pubmed/34571103 http://dx.doi.org/10.1016/j.cpcardiol.2021.100992 |
_version_ | 1784572107719442432 |
---|---|
author | Goudarzi, Ehsan Yousefimoghaddam, Fateme Ramandi, Alireza Khaheshi, Isa |
author_facet | Goudarzi, Ehsan Yousefimoghaddam, Fateme Ramandi, Alireza Khaheshi, Isa |
author_sort | Goudarzi, Ehsan |
collection | PubMed |
description | For more than 2 years, health care systems have been floundering in a massive crisis of coronavirus disease 2019 (COVID-19) pandemic. While acute respiratory distress syndrome is the main complication in patients with COVID-19, as the pandemic continues, more data about the nonrespiratory effects of the coronavirus is obtained, including developing Coagulopathy-related manifestations, in the form of venous and arterial thromboembolism. Although arterial thrombosis a rare complication of this disease, it proves to be an effective factor in the mortality and morbidity of COVID-19 patients. The pathophysiology of thrombosis reveals a complex relation between hemostasis and immune system that can be disrupted by COVID-19. Thrombectomy, anticoagulant therapy, and thrombolysis are the main treatments in these patients. In addition, appropriate thromboprophylaxis treatment should be considered in COVID-19 patients. In this article, we have successfully reviewed the arterial thrombotic events in patients reported around the world, including the diagnostic and management method of choice. |
format | Online Article Text |
id | pubmed-8462005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Mosby-Year Book |
record_format | MEDLINE/PubMed |
spelling | pubmed-84620052021-09-24 COVID-19 and Peripheral Artery Thrombosis: A Mini Review Goudarzi, Ehsan Yousefimoghaddam, Fateme Ramandi, Alireza Khaheshi, Isa Curr Probl Cardiol Article For more than 2 years, health care systems have been floundering in a massive crisis of coronavirus disease 2019 (COVID-19) pandemic. While acute respiratory distress syndrome is the main complication in patients with COVID-19, as the pandemic continues, more data about the nonrespiratory effects of the coronavirus is obtained, including developing Coagulopathy-related manifestations, in the form of venous and arterial thromboembolism. Although arterial thrombosis a rare complication of this disease, it proves to be an effective factor in the mortality and morbidity of COVID-19 patients. The pathophysiology of thrombosis reveals a complex relation between hemostasis and immune system that can be disrupted by COVID-19. Thrombectomy, anticoagulant therapy, and thrombolysis are the main treatments in these patients. In addition, appropriate thromboprophylaxis treatment should be considered in COVID-19 patients. In this article, we have successfully reviewed the arterial thrombotic events in patients reported around the world, including the diagnostic and management method of choice. Mosby-Year Book 2022-10 2021-09-24 /pmc/articles/PMC8462005/ /pubmed/34571103 http://dx.doi.org/10.1016/j.cpcardiol.2021.100992 Text en . Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Goudarzi, Ehsan Yousefimoghaddam, Fateme Ramandi, Alireza Khaheshi, Isa COVID-19 and Peripheral Artery Thrombosis: A Mini Review |
title | COVID-19 and Peripheral Artery Thrombosis: A Mini Review |
title_full | COVID-19 and Peripheral Artery Thrombosis: A Mini Review |
title_fullStr | COVID-19 and Peripheral Artery Thrombosis: A Mini Review |
title_full_unstemmed | COVID-19 and Peripheral Artery Thrombosis: A Mini Review |
title_short | COVID-19 and Peripheral Artery Thrombosis: A Mini Review |
title_sort | covid-19 and peripheral artery thrombosis: a mini review |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462005/ https://www.ncbi.nlm.nih.gov/pubmed/34571103 http://dx.doi.org/10.1016/j.cpcardiol.2021.100992 |
work_keys_str_mv | AT goudarziehsan covid19andperipheralarterythrombosisaminireview AT yousefimoghaddamfateme covid19andperipheralarterythrombosisaminireview AT ramandialireza covid19andperipheralarterythrombosisaminireview AT khaheshiisa covid19andperipheralarterythrombosisaminireview |